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TOLL-LIKE RECEPTOR EXPRESSION IN CELL LINES AND 
PRIMARY TUMOUR MATERIAL 
Anti-inflammatory pathways such as those recruited in response to the activation of the glucocorticoid 
receptor by ligands like Dexamethasone, might have an adverse effect on the response of tumour cells to 
therapy. In a prophylactic mode, mechanisms that reduce inflammation might be of significant benefit in 
reducing the likelihood of tumour development. Toll-like receptors form a part of the pattern recognition 
receptors that are responsible for innate immunity in the cells of the immune system. Recent finding of Toll¬ 
like receptors in many somatic tissues and especially in the various forms of tumors provide novel ap¬ 
proaches as for the development of specifically targeted chemotherapeutic agents. Current research project 
focused on the investigation of the expression patterns of the Toll-like receptors in the primary meningioma 
biopsies and cell lines of different origin. 
Although anti-inflammatory responses in the im­
mune system involve direct downregulation of the 
leukocyte activity and reduction in the cytokine pro­
duction [1]. Toll receptor (TLR) proteins that are 
involved in a fist-line response to infectious agents, 
such as bacteria and fungi (as described in an earlier 
section of this thesis), are also regulated. Therefore, 
in gene profiling studies, glucocorticoids have been 
shown to alter the expression of Toll 2 and Toll 4 
[2]. A rather fundamental question that might be 
asked, therefore, is whether tumour cells express 
functional toll receptors and whether this property 
can be exploited for therapeutic use. To address this, 
PCR studies were conducted on the expression of 
toll-like receptors in tumour cell lines and primary 
human tumour material. 
Expression of Toll receptors in human cell lines 
A PCR protocol was established based on recent 
studies on the expression of Toll receptors in normal 
human cells [3]. Primer sequences were selected 
and a standard PCR reaction was performed on cD-
NA generated from RNA extracted and from tumour 
cells In order to check the specificity of the primers, 
a PCR reaction was first performed on the chronic 
myeloid leukemia cell line, K562. Fig. 1 shows that 
this cell line is indeed of leukocyte in origin due to 
the expression of the pan-leukocyte marker, CD45 
and with the exception of TLR 8 and 9, all other re­
ceptors are clearly expressed. The sizes of the PCR 
products were determined by comparative analysis 
with known molecular size markers and were con¬ 
firmed to be consistent with product sizes reported 
in the literature by using a UV-Itec gel-documenta¬ 
tion and band analysis system. 
All PCR products were checked with a gel-docu¬ 
mentation system and sizes of the PCR products 
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corresponding to the predicted product sizes are as 
indicated below. Slight variation in the product siz¬ 
ing is due to the imperfection and artifacts during 
electrophoresis. Fig.1. is shown as a negative. Prod¬ 
ucts were compared to the known size markers in 
order to determine their size (Table 1). 
Fig. 1. TLR expression in the CD45+K562 human chronic 
myeloid leukemia cells 
Table 1. Predicted and actual sizes of the RT-PCR prod­
ucts for the TLR receptor expression analysis 
Actual size of the PCR product was identified by 
comparison to a known size ladder marker (Hyper-
ladder 100bp) using a gel-doc. system. 
Colorectal cancers are commonly associated 
with chronic inflammatory conditions and informa¬ 
tion on receptor expression in cell lines derived 
from this neoplastic condition should reflect the pat­
tern of Toll-like receptor expression in the meningi­
oma tumour if their onset is associated with inflam¬ 
mation. However this is a speculative idea that is 
based on the assumptions that innate immune re¬ 
sponses to the chronic inflammation mediated via 
toll-like receptors are essentially identical in the tis¬ 
sues of different origin. COLO and CACO cell lines 
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were initially screened with the PCR assay for the 
Toll-like receptor expression. Table 2 shows that as 
many as 6 members of the Toll receptor family 
(TLR 1-6) were expressed in COLO cell line and 8 
receptors (1-6, 9 and 10) were found in the CACO 
cells. 
Further studies on other cells and tumour cell 
lines indicated that Toll receptors were expressed in 
a wide range of cells of unrelated origin, although 
with some subtle differences in the expression pat¬ 
terns. 
The data presented in Table 2 represents a con¬ 
sensus from two different passages of tumour cells 
where each PCR reaction, for each receptor, was 
performed in triplicate. The pan-leukocytic marker, 
CD45, was included in the screening for the optimi¬ 
sation of the thermal cycling conditions as it was 
intended for later screening of primary human tu¬ 
mour-derived cells in order to exclude the possibil¬ 
ity of leukocyte infiltration in the tissue. This step 
was considered important due to the fact that cells 
of the immune system are known to have high-level 
expression of all members of the Toll-like receptors 
and this might invalidate studies on RNA extracted 
from sections of primary tumour material, where a 
mixed population of cells is present. 
Toll-like receptor expression 
in primary human tumour material 
The data presented above on the presence of 
Toll-like receptor members in a range of tumour 
cell lines further substantiates the link between 
chronic inflammatory conditions and the establish­
ment and the promotion of cancer. More impor¬ 
tantly, it establishes a link between initiators of 
inflammatory reactions and a direct response at the 
level of the tumour cell. There are always potential 
problems using tumour cell lines, as due to genetic 
and epigenetic drifts and senescence changes over 
the time that cells are kept in culture, receptor ex¬ 
pression patterns may not always reflect those of 
primary tumour material. As access was available 
to primary tumour material through the Depart¬ 
ment of Neuro-Endocrinology at the Max Planck 
Institute of Psychiatry in Munich, studies were 
conducted on primary meningioma. Due to the 
complexity of Meningioma tumour pathophysiol-
ogy (see Appendix for a screening of Meningioma 
tissue Histopathology), a great deal of care was de¬ 
voted during sample preparation for the RT-PCR 
screening, in order to avoid any possibility of leu¬ 
kocyte contamination. Dissections of the tumour 
biopsies were performed under a binocular micro¬ 
scope and a fresh set of disposable scalpels was 
used for each sample. Using these procedures, 
meningioma biopsies were selected to be screened 
for the expression of Toll-like receptor family. RT-
PCR products were separated on 1.5% agarose gels 
stained with ethidium bromide and visualized un¬ 
der UV light. Fig. 2. shows the TLR expression 
pattern in two different meningioma tumours (fe¬ 
male and male-derived tumours respectively) as 
determined by RT-PCR. 
By screening 8 more tumours in this way, it soon 
became apparent that a large proportion of the TLR 
receptors were expressed in the meningioma tu¬ 
mours with Toll-1, 2, 3, 4, 5, 6, 9, and 10 being 
present in most of samples (see Table 3). Some tu¬ 
mours showed subtle differences in the expression 
patterns and no samples had a CD45 positive band. 
The latter finding indicated that the Toll receptor ex­
pression detected in the tumour samples was not due 
to overwhelming infiltration by cells of the immune 
system as was genuinely due to the expression of 
the receptor by the cells that constituted the tu¬ 
mour. 
Table 2. Expression of Toll-like receptors in the human cancer cell lines of different origin as determined by RT-PCR 
Toll like receptors 
CD45 
Cell line Origin 1 2 3 4 5 6 7 8 9 10 
COLO Colorectal + + + + + + - - - - -
CACO Colorectal + + + + + + - - + + -
U87MG Glial + + + + + + - - + + -
LOVO Colorectal + + + + + + - - - + -
MCF-7 Breast + + + + + + - - + + -
Eahy 962 Endothelial + + + + + + - - + + -
K562 Hematopoietic + + + + + + + 
- -
+ + 
Fig. 2. Comparison of the expression of Toll-like receptors 1-10 in primary human meningioma tumour material derived from 
one female and one male patient. PCR product sizes were consistent with those obtained for the study on different cell lines 
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Table 3. Grouped analysis of the Toll receptor expression in meningioma tumour tissue 
Toll receptor expression 
CD45 
Tumour number Male/Female 1 2 3 4 5 6 7 8 9 10 
1 F + + + + + + - - - - -
2 M + + + + + + - - + + -
3 M + + + + + + - - + + -
4 F + + + + + - - - + + -
5 F + + + + + + - - + + -
6 M + + + + + + - - - + -
7 F + + + + - + - - + + -
8 F + + + + - + - - + + -
9 F + + + + + + - - + + -
10 M + + + + + 
- - -
+ + 
-
The results presented in Table 3 are consensus 
values from duplicate PCR reactions for each recep¬ 
tor. 
Data presented in Table 3 on the expression of 
Toll-like receptors in primary human meningioma 
tumour cell material and the data derived from the 
cell lines supports the view that Toll receptor ex¬ 
pression is a common finding in human tumour 
cells. Whether receptors are constitutively expressed 
or their expression is induced or decreased in re¬ 
sponse to anti-inflammatory agents is another ques¬ 
tion that should be answered. 
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ЕКСПРЕСІЯ TOLL-LIKE-РЕЦЕПТОРІВ У КЛІТИННИХ ЛІНІЯХ 
ТА ДЕЯКИХ ЗЛОЯКІСНИХ ПУХЛИНАХ 
Протизапальні механізми, що регулюються через глюкокортикоїдний рецептор та активують­
ся такими лігандами, як дексаметазон, можуть відігравати негативну роль у відповіді пухлини на 
хіміотерапію. Водночас профілактичні заходи, що зменшують ризик виникнення хронічних запаль­
них процесів, можуть зменшити ризик неоплазматичного перетворення та розвитку ракової пухли­
ни. Toll-like-рецептори, які активуються широким спектром структурно споріднених молекул, є ос­
новними медіаторами вродженого імунітету. Нещодавні дослідження показали наявність Toll-likе-
рецепторів у соматичних тканинах, а також у декількох типах пухлин, що надає нові можливості 
у розробці новітніх протипухлинних препаратів. Проект сфокусовано на вивченні експресії Toll-like-
рецепторів у біоптатах менінгітом та у клітинних лініях різного походження. 
